BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Pseudomonas infection
,
Prostate
,
Holistic medicine
,
Aspirin
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nuclear receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MDAMB231 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer HS578T cells treated with ligand perturbagens
Breast cancer MCF7 cells treated with nuclear receptor agonists
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective…
Opportunities and challenges in targeting orphan nuclear receptors.
Nuclear receptor Rev-erbα role in fine-tuning erythropoietin gene expression.
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.
The nuclear receptor REV-ERBα integrates circadian clock and energy metabolism.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effect…
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Act…
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ